Subscribe: LexisNexis® Mealey's™ Emerging Drugs & Devices Legal News
http://www.lexisnexis.com/mealeys/rss/legalnews_emergingdrugs&devices.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
court  dec  depuy orthopaedics  depuy  federal  judge  litigation  mdl docket  mdl  multidistrict litigation  new  orthopaedics 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: LexisNexis® Mealey's™ Emerging Drugs & Devices Legal News

LexisNexis® Mealey's™ Emerging Drugs & Devices Legal News



Headline Emerging Drugs & Devices Legal News from LexisNexis®



 



Omnibus Summary Judgment Granted In Lipitor Diabetes MDL After Causation Rulings
CHARLESTON, S.C. - The South Carolina federal judge overseeing the Lipitor diabetes multidistrict litigation on Jan. 3 granted partial summary judgment to defendant Pfizer Inc., ordered all plaintiffs to show cause why he should not grant summary judgment in their cases and suggested that no more cases be transferred into the MDL (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2502, No. 14-mn-2502, D. S.C., Charleston Div.).



DePuy Pinnacle Hip MDL Judge More Than Halves $1B Punitives For 6 Plaintiffs
DALLAS - A Texas federal judge on Jan. 3 more than halved $1 billion in punitive damages for six plaintiffs in the second DePuy Pinnacle hip multidistrict litigation bellwether trial, and the plaintiffs on the same day filed a notice that they will appeal the reduction (In Re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244, No. 13-3631, Rosa Metzler, et al. v. DePuy Orthopaedics, Inc., et al., No. 12-2066, Michael Weiser v. DePuy Orthopaedics, Inc., et al., No. 13-3631, Judith Rodriguez v. DePuy Orthopaedics, Inc., et al., No. 13-3938, Linda Standerfer v. DePuy Orthopaedics, Inc., et al., No. 14-1730, Kathleen Davis, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-1767, Marvin Andrews, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-3484, N.D. Texas, Dallas Div.).



Nonsuit Granted In Pennsylvania Risperdal Gynecomastia Trial
PHILADELPHIA - A Pennsylvania state court judge on Dec. 13 granted a motion for a nonsuit in a Risperdal gynecomastia case that was 10 days into trial in the Philadelphia County Common Pleas Court (TM, et al. v. Janssen Pharmaceuticals, Inc., et al., No. 130501076, Pa. Comm. Pls., Philadelphia Co.).



Allegation Of Counterfeit Spinal Hardware Fails Anti-SLAPP Challenge
LOS ANGELES - A California appeals court on Dec. 19 affirmed the striking of an alleged strategic lawsuit against public participation (SLAPP) lawsuit against two plaintiff attorneys involving an underlying lawsuit alleging that a former hospital owner used counterfeit orthopedic hardware in patients (Healthsmart Pacific, Inc., et al. v. Brian S. Kabateck, et al., No. B264300, Calif. App., 2nd Dist., Div. 1; 2016 Cal. App. Unpub. LEXIS 9117).



Drug Maker To Pay Nearly $520M To Settle SEC, Justice Department FCPA Claims
WASHINGTON, D.C. - Teva Pharmaceutical Industries Ltd. and its wholly owned Russian subsidiary will pay nearly $520 million to settle claims with government authorities over the generic drug manufacturer's involvement in a bribery scheme in violation of the Foreign Corrupt Practices Act (FCPA), according to press releases issued Dec. 22 by the U.S. Department of Justice and the Securities and Exchange Commission (United States of America v. Teva Pharmaceutical Industries Ltd., et al., No. 16-cr-20967, S.D. Fla.; and Securities and Exchange Commission v. Teva Pharmaceutical Industries Ltd., et al., No. 16-cv-25298, S.D. Fla.).



Forest Labs To Pay $38M To Settle Kickback Allegations Involving 3 Drugs
WASHINGTON, D.C. - Forest Laboratories LLC and Forest Pharmaceuticals Inc. have agreed to pay $38 million to resolve civil allegations that they violated the federal False Claims Act by paying kickbacks to physicians to prescribe the drugs Bystolic, Savella and Namenda, the U.S. Justice Department said Dec. 15 in a press release (United States of America, ex rel. Kurt Kroening v. Forest Pharmaceuticals Incl., et al., No. 12-366, E.D. Wis.).



1st Circuit Affirms Dismissal Of False Claims Involving Vagus Nerve Stimulator
BOSTON - The First Circuit U.S. Court of Appeals on Dec. 16 affirmed dismissal of a whistleblower lawsuit alleging that Cyberonics Inc. pushed premature replacements of its neurostimulators, agreeing with the district court that the relator failed to show that false claims were submitted to federal health care programs (Andrew Hagerty, ex rel. United States, et al. v. Cyberonics, Inc., No. 16-1304, 1st Cir.; 2016 U.S. App. LEXIS 22405).



Product Defect Plaintiff Tells High Court: Rights Were Violated By Testimony Exclusion
WASHINGTON, D.C. - In a product defect lawsuit arising out of silicone in a breast implant, a woman on Dec. 5 petitioned the U.S. Supreme Court to answer whether her right to fundamental fairness under the Seventh and 14th amendments were violated when a district court's exclusion of expert testimony was affirmed "based upon disingenuous legal legerdemain" (Beverly Ezra v. DCC Litigation Facility Inc., No. 16-740, U.S. Sup.).



NECC Murder Defendant Moves To Dismiss Federal Murder Charge
BOSTON - The former president and chief pharmacist of New England Compounding Center (NECC) on Dec. 14 filed another motion seeking to dismiss the murder charges he faces in January and to get access to grand jury minutes (United States of America v. Barry J. Cadden, et al., No. 14-10363, D. Mass.).



10th Circuit Affirms Denial Of Injunction Against Utah's Contact Lens Pricing Law
DENVER - A split panel of the 10th Circuit U.S. Court of Appeals on Dec. 19 backed a trial court's denial of an injunction against Utah's contact lens pricing (Johnson & Johnson Vision Care, Inc., et al. v. Sean D. Reyes, et al., Nos. 15-4071, 15-4072, 15-4073, 10th Cir.; 2016 U.S. App. LEXIS 22444).



Generic Drug Makers Named In Criminal, Civil Complaints For Price Fixing, Bid Rigging
PHILADELPHIA - On Dec. 14 and 15, separate criminal and civil complaints were filed in federal courts by the federal government and 20 states against two former executives and six generic drug manufacturers accusing them of conspiring to fix the prices, rig drug bids and allocate markets for the antibiotic doxycycline and the diabetes drug glyburide (United States of America v. Jeffrey Glazer, No. 16-cr-506, United States of America v. Jason Malek, No. 16-cr-508, E.D. Pa., The State of Connecticut, et al. v. Aurbodino Pharma USA, Inc., et al., No. 16-2056, D. Conn.).



Judge Grants Final Approval Of $468M Settlement In Pfizer Securities Suit
NEW YORK - A federal judge in New York on Dec. 21 granted final approval of a $486 million settlement in a securities class action lawsuit between shareholders and certain of its executive officers, ruling that the settlement is fair, reasonable and adequate (In re Pfizer Inc. Securities Litigation, No. 04-9866, S.D. N.Y.).



Stock Promotion Articles Not Actionable In Securities Class Action, Panel Rules
ATLANTA - A pharmaceutical company and certain of its officers and directors cannot be held liable for articles promoting the company's new nonalcoholic steatohepatitis drug because, even though the company paid stock promoters to write the articles, the defendants did not actually make any of the alleged misstatements, an 11th Circuit U.S. Court of Appeals panel ruled Dec. 15 (In re Galectin Therapeutics Inc. Securities Litigation, No. 16-10324, 11th Cir.; 2016 U.S. Dist. LEXIS 22317).






$1B Verdict Returned In 6-Plaintiff Pinnacle Hip MDL Bellwether Trial
DALLAS - A Texas federal jury on Dec. 1 returned a verdict of more than $1 billion in favor of six plaintiffs in the second DePuy Pinnacle hip multidistrict litigation bellwether trial (In Re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244, No. 13-3631, Rosa Metzler, et al. v. DePuy Orthopaedics, Inc., et al., No. 12-2066, Michael Weiser v. DePuy Orthopaedics, Inc., et al., No. 13-3631, Judith Rodriguez v. DePuy Orthopaedics, Inc., et al., No. 13-3938, Linda Standerfer v. DePuy Orthopaedics, Inc., et al., No. 14-1730, Kathleen Davis, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-1767, Marvin Andrews, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-3484, N.D. Texas, Dallas Div.).



New Trial Denied In $146.2M Pinnacle Hip Bellwether MDL Trial; Order Sealed
DALLAS - A Texas federal judge on Dec. 9 denied a defense motion for a new trial in a Pinnacle hip case that resulted in a $146.2 million judgment against DePuy Orthopaedics Inc. and parent company Johnson & Johnson (In Re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244, No. 11-md-2244, Margaret Aoki v. Johnson & Johnson Services, Inc., et al., No. 13-1071, Jacqueline Christopher v. Johnson & Johnson Services, Inc., et al., No. 14-194, Donald Greer v. Johnson & Johnson Services, Inc., et al., No. 12-1672, Susan Klusmann v. Johnson & Johnson Services, Inc., et al., No. 11-2800, Robert Peterson v. Johnson & Johnson Services, Inc., et al., No. 11-1941, N.D. Texas, Dallas Div.).



7th Circuit Reverses Quantum Meruit Fee In ASR Hip Case For Detailed Analysis
ST. LOUIS - The Seventh Circuit U.S. Court of Appeals on Dec. 1 reversed a disputed attorney fee in a DePuy ASR hip case and remanded it to a district court for an explanation of how the judge arrived at her 35 percent quantum meruit fee (Dustan Dobbs v. DePuy Orthopaedics, Inc., et al. v. George E. McLaughlin, et al., No. 16-2135, 7th Cir.; 2016 U.S. App. LEXIS 21492).



Coloplast Human Tissue-Based Pelvic Mesh Claim Protected By State Blood Shield Law
CHARLESTON, W.Va. - The West Virginia federal judge overseeing the Coloplast Corp. pelvic mesh multidistrict litigation on Dec. 9 dismissed six claims in one plaintiff's case because the device is made of human tissue and is thus protected by the South Carolina blood shield statute (In Re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation, MDL Docket No. 2387, No. 12-md-2387, Jane Jones v. Coloplast Corp., No. 14-11148, S.D. W.Va., Charleston Div.).



Mentor ObTape MDL Judge Reverses Ruling On Statute Of Limitations
COLUMBUS, Ga. - The Georgia federal judge overseeing the Mentor ObTape pelvic mesh multidistrict litigation on Dec. 5 reversed summary judgment in one "unique" case, finding on reconsideration that there is a factual dispute as to when the plaintiff became aware that the device was the cause of her injuries (In Re: Mentor Corp. ObTape Transobturator Sling Products Liability Litigation, MDL Docket No. 2004, No. 08-md-2004, , MDL Docket No. 2004, No. 08-md-2004, Janice Young, et al. v. Mentor Corp., No. 13-476, M.D. Ga.; 2016 U.S. Dist. LEXIS 167082).



West Virginia Pelvic Mesh MDL Plaintiffs Must Show Alternative, Feasible Design
CHARLESTON, W.Va. - The West Virginia federal judge overseeing the Ethicon pelvic mesh multidistrict litigation on Dec. 9 reversed himself and found that West Virginia law requires 31 plaintiffs to show that there was an alternative, feasible design (Terreski Mullins, et al. v. Ethicon, Inc., et al., No 12-2952, S.D. W.Va., Charleston Div.; 2016 U.S. Dist. LEXIS 170445).



Summary Judgment Partially Granted In C.R. Bard Pelvic Mesh Case
CHARLESTON, W.Va. - The West Virginia federal judge overseeing the C.R. Bard Inc. pelvic mesh multidistrict litigation on Dec. 6 granted partial summary judgment in the case of a Connecticut plaintiff but denied summary judgment on the issue of punitive damages and other claims (Penny Havanick v. C.R. Bard, Inc., No. 12-2312, S.D. W.Va., Charleston Div.; 2016 U.S. Dist. LEXIS 168079).



Bard Pelvic Mesh Plaintiff Comes Away With Only Strict Liability, Warning Claims
CHARLESTON, W.Va. - A plaintiff in a C.R. Bard pelvic mesh case will not be able to pursue her claims of manufacturing defect, breach implied and express warranty and negligent inspection, packaging, marketing and selling, but will be able to press her claim of strict liability and negligent failure to warn, a multidistrict litigation judge ruled Dec. 6 (Katie Rodenkirch-Kleindl, et al. v. C.R. Bard, Inc., No. 13-26026, S.D. W.Va., Charleston Div.; 2016 U.S. Dist. LEXIS 168078).



Invokana Diabetes Drug MDL Created, Assigned To Judge Martinotti In New Jersey
WASHINGTON, D.C. - Almost 100 federal lawsuits alleging that the diabetes drug Invokana causes diabetic ketoacidosis and kidney damages were centralized Dec. 7 before Judge Brian R. Martinotti of the U.S. District Court for the District of New Jersey (In Re: Invokana [Canagliflozin] Products Liability Litigation, MDL Docket No. 2750, JPMDL).



FDA Concludes Actos Is Linked To Bladder Cancer After Literature Review
SILVER SPRING, Md. - The Food and Drug Administration on Dec. 12 said an updated review of medical studies has led it to conclude that the diabetes drug Actos may be linked to an increased risk of bladder cancer.



Lipitor MDL Judge Remands Additional California Cases
CHARLESTON, S.C. - The South Carolina federal judge overseeing the Lipitor diabetes multidistrict litigation on Dec. 9 remanded another group of California cases to state court, finding that a California-based distributor was not fraudulent joined (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 14-mn-2502, D. S.C.).



Alabama Federal Magistrate Judge Finds No Jurisdiction Over Johnson & Johnson
SELMA, Ala. - An Alabama federal magistrate judge on Dec. 8 said the court lacks general and specific jurisdiction over Johnson & Johnson (J&J) in a DePuy hip case because the two entities are separate (Maeola Goldthrip, et al. v. Johnson & Johnson, No. 15-00651, S.D. Ala., N. Div.; 2016 U.S. Dist. LEXIS 170801).



Taxotere MDL Judge Names Settlement Committees
NEW ORLEANS - A Louisiana federal judge overseeing the Taxotere hair loss multidistrict litigation on Dec. 13 took the unusual step of appointing plaintiff and defense committees to regularly discuss settlement separately from litigation-related work (In Re: Taxotere [Docetaxel] Products Liability Litigation, MDL Docket No. 2740, No. 16-md-2740, E.D. La.).



C-Qur Surgical Mesh MDL Created, Sent To Judge McCafferty In New Hampshire
WASHINGTON, D.C. - Twenty-one federal lawsuits in which plaintiffs allege that they suffered an inflammatory reaction to the C-Qur surgical mesh patch were centralized Dec. 8 in a multidistrict litigation before U.S. Judge Landya B. McCafferty of the District of New Hampshire (In Re: Atrium Medical Corp. C-Qur Mesh Products Liability Litigation, MDL Docket No. 2753, JPMDL).



Rhode Island Judge Denies Dismissal Of Composix Kugel Hernia Patch Suit
PROVIDENCE, R.I. - A Rhode Island judge on Nov. 28 denied a motion by Davol Inc. and parent company C.R. Bard Inc. to dismiss a plaintiff's complaint involving the Composix Kugel Hernia Patch, finding that the plaintiff has adequately pleaded his claims (Wayne Smith, et al. v. Davol Inc., et al., No. PC-08-8307, Rhode Island Super., Providence).



Sperm Donor MDL Denied By Federal Judicial Panel; Minimal Cases Cited
WASHINGTON, D.C. - Six federal lawsuits alleging that a sperm bank misrepresented the qualities of a donor do not need to be centralized in a multidistrict litigation, the Judicial Panel on Multidistrict Litigation (JPMDL) ruled Dec. 7 (In Re: Xytex Corporation Sperm Donor Products Liability Litigation, MDL Docket No. 2751, JPMDL).



6 Former Insys Executives Indicted For Paying Kickbacks For Opioid Scripts
BOSTON - Six former executives and managers of drug maker Insys Therapeutics Inc. were indicted Dec. 6 for racketeering, mail fraud and wire fraud conspiracy for allegedly bribing medical practitioners to prescribe Subsys, a fentanyl-containing pain drug, and for defrauding medical insurers, according to a criminal information unsealed Dec. 8 (United States of America v. Michael L. Babich, et al., No. 16-cr-10343, D. Mass.).



Investor Sues Drug Company, Others Over Involvement In Price-Fixing Scheme
NEW YORK - A specialty pharmaceutical company and several of its current and former officers and directors concealed their involvement in an illegal generic drug price-fixing scheme in violation of federal securities laws, an investor argues in a Nov. 8 complaint filed in New York federal court (Charles R. Haile Jr. v. Allergan plc, et al., No. 16-8661, S.D. N.Y.).






1st Circuit Affirms Dismissal Of Actos Prediabetes Off-Label False Claims Lawsuit
BOSTON - The First Circuit U.S. Court of Appeals on Nov. 22 affirmed dismissal of an Actos off-label whistle-blower lawsuit, agreeing with a lower court judge that the relator failed to plead that the alleged actions resulted in false claims being filed with state Medicare programs (Peter W. Lawton, ex rel. United States of America v. Takeda Pharmaceutical Company, Ltd., et al., No. 16-1382, 1st Cir.; 2016 U.S. App. LEXIS 20943).



11th Circuit: Hip Plaintiff Missed Deadline By Withholding Service
ATLANTA - The 11th Circuit U.S. Court of Appeals on Nov. 28 agreed with a lower court that in filing a DePuy hip lawsuit but withholding service in hopes of a settlement, a plaintiff's claim was actually not initiated until after the applicable two-year statute of limitations (Maeola Goldthrip, et al. v. DePuy Orthopaedics, Inc., et al., No. 16-14002, 11th Cir.; 2016 U.S. App. LEXIS 21192).



Insured Did Not Comply With Policy's Consent-To-Settle Provision, Appeals Panel Says
CINCINNATI - An excess liability insurer has no duty to reimburse an insured for underlying settlements related to defective knee implants because the policy's consent-to-settle provision clearly required the insured to seek the excess insurer's consent and the insured failed to do so, the Sixth Circuit U.S. Court of Appeals said Nov. 18 in reversing a Michigan federal judge's ruling (Stryker Corp., et al. v. National Union Fire Insurance Company of Pittsburgh, Pa. et al., Nos. 15-1657 and 15-1664, 6th Cir.; 2016 U.S. App. LEXIS 20653).



6th Circuit Denies Appeal Of Dow Breast Implant Order By Korean Claimants
CINCINNATI - A Sixth Circuit U.S. Court of Appeals panel on Nov. 23 affirmed a consent order that resulted in certain Korean women being denied injury claims from the Dow Corning Corp. silicone breast implant settlement (In Re: Settlement Facility Dow Corning Trust, Korean Claimants v. Debtor's Representatives, et al., No. 15-2548, 6th Cir.; 2016 U.S. App. LEXIS 21167).



1st Circuit Won't Grant New Trial In Nexium Antitrust Case For Alleged Errors
BOSTON - The First Circuit U.S. Court of Appeals on Nov. 21 said a district court judge committed no errors in a Nexium generic antitrust case that ended in a defense verdict for defendant AstraZeneca LP (In Re: Nexium [Esomeprazole] Antitrust Litigation, American Sales Company, et al. v. AstraZeneca LP, et al., Nos. 15-2005, 15-2006, 15-2007, 1st Cir.; 2016 U.S. App. LEXIS 20845).



U.K. Investigation Material About Paxil Expert Excluded From Suicide Trial
CHICAGO - Evidence about a United Kingdom investigation into plaintiff antidepressant expert witness Dr. David Healy will be excluded from a Jan. 17 suicide trial after an Illinois federal judge on Nov. 21 said the investigation resulted in no action against Healy and is not relevant to his testimony or to the case (Wendy Dolin, et al. v. SmithKline Beecham Corporation, et al., No. 12-6403, N.D. Ill., Eastern Div.).



Kimberly-Clark Wants Surgical Gown Class Stayed Pending 9th Circuit Petition
LOS ANGELES - Kimberly-Clark Corp. on Nov. 18 asked a California federal court to stay a certified class action involving the company's surgical gowns while it waits for a circuit court to rule on a petition for interlocutory appeal (Hrayr Shahinian, M.D., et al. v. Kimberly-Clark Corporation, et al., No. 14-83390, C.D. Calif.).



Plaintiffs In Pinnacle Hip Bellwether Trial Will Seek State Consumer Law Penalties
DALLAS - Six plaintiffs in an ongoing DePuy Pinnacle hip multidistrict litigation bellwether trial on Nov. 28 told a Texas federal court that after the verdict, they intend to ask the court to determine that defendant DePuy Orthopaedics Inc. violated California's unfair competition law (UCL) and to order equitable relief (In Re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244, No. 13-3631, Rosa Metzler, et al. v. DePuy Orthopaedics, Inc., et al., No. 12-2066, Michael Weiser v. DePuy Orthopaedics, Inc., et al., No. 13-3631, Judith Rodriguez v. DePuy Orthopaedics, Inc., et al., No. 13-3938, Linda Standerfer v. DePuy Orthopaedics, Inc., et al., No. 14-1730, Kathleen Davis, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-1767, Marvin Andrews, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-3484, N.D. Texas, Dallas Div.).



DePuy Can't Use Video Depositions Only In 3rd Pinnacle Hip Bellwether
DALLAS - DePuy Orthopaedics Inc. will have to find another way to present testimony of five experts in an ongoing Pinnacle hip multidistrict litigation bellwether trial after the presiding judge on Nov. 17 sustained a plaintiffs' objection to having testimony entered by video depositions (In Re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation, MDL Docket No. 2244, No. 11-md-2244, Rosa Metzler, et al. v. DePuy Orthopaedics, Inc., et al., No. 12-2066, Michael Weiser v. DePuy Orthopaedics, Inc., et al., No. 13-3631, Judith Rodriguez v. DePuy Orthopaedics, Inc., et al., No. 13-3938, Linda Standerfer v. DePuy Orthopaedics, Inc., et al., No. 14-1730, Kathleen Davis, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-1767, Marvin Andrews, et al. v. DePuy Orthopaedics, Inc., et al., No. 15-3484,N.D. Texas, Dallas Div.).



Judge In Fungal Meningitis Criminal Case Won't Reconsider 3 Dismissals
BOSTON - A judge overseeing the New England Compounding Center (NECC) criminal case on Nov. 16 denied the United States' motion to reconsider the dismissal of claims against three defendants, saying the federal government attempted to amend the indictment and add "one completely new argument" (United States of America v. Barry J. Cadden, et al., No. 14-10363, D. Mass.).



Fungal Meningitis MDL Documents Not Available To Criminal Defendant
BOSTON - A criminal defendant in the New England Compounding Center (NECC) fungal meningitis outbreak cannot access discovery material from the personal injury multidistrict litigation, but a co-defendant can share materials he got while he was part of the MDL, a Massachusetts federal judge ruled Nov. 17 (In Re: New England Compounding Pharmacy, Inc. Products Liability Litigation, MDL Docket No. 2419, No. 13-md-2419, D. Mass.).



Fungal Meningitis Defendant Wants Criminal Trial Continued To Review Evidence
BOSTON - A defendant facing federal murder charges in connection with the New England Compounding Center (NECC) fungal meningitis outbreak on Nov. 25 asked a Massachusetts federal court to continue his January trial, saying he is at a disadvantage because he only recently got access to discovery from the personal injury multidistrict litigation that is likely to be used against him (United States of America v. Glenn Chin, No. 14-cr-10363, D. Mass.).



Surgical Mesh Plaintiff Appeals Dismissal Of Suit Against 2 Manufacturers
CHATTANOOGA, Tenn. - A surgical mesh plaintiff on Nov. 22 filed a notice of appeal with the Sixth Circuit U.S. Court of Appeals of a Tennessee federal court's dismissal of his complaint for failure to plead specific defects or specific causation (Ronnie Moore v. C.R. Bard, Inc., et al., No. 16-161, E.D. Tenn.; 2016 U.S. Dist. LEXIS 156923).



Taxotere MDL Judge Appoints Plaintiff, Defense Counsel To Leadership Posts
NEW ORLEANS - The Louisiana federal judge overseeing the Taxotere multidistrict litigation on Nov. 7 made initial leadership appointments (In Re: Taxotere [Docetaxel] Products Liability Litigation, MLD Docket No. 2470, No. 14-md-2740, E.D. La.).



Former FDA Deputy To Pay $127,496 For Insider Trading Role Involving Generics
NEW YORK - A former Food and Drug Administration deputy director turned industry lobbyist was enjoined Nov. 14 from violating the Securities Exchange Act for his role in giving FDA insider information to a hedge fund manager who reportedly made millions from the scheme (Securities and Exchange Commission v. Sanjay Valvani, et al., No. 16-4512, S.D. N.Y.).



Former Valeant, Pharmacy Executives Charged With Running Kickback Scheme
NEW YORK - Former Valeant Pharmaceuticals International Inc. executive Gary Tanner and former Phildor Rx Services LLC CEO Andrew Davenport have been charged with fraud for allegedly running a kickback scheme, the U.S. attorney for the Southern District of New York announced Nov. 17 (United States of America v. Gary Tanner, et al., No. 16-7338, S.D. N.Y.).